20 studies found for:    " January 02, 2007":" February 02, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 02, 2007":" February 02, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)
2 Terminated Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
Condition: HIV Infection
Interventions: Drug: atazanavir;   Drug: lopinavir/ritonavir
3 Unknown  Assessment of Asymptomatic Heart Disease in Children With HIV
Condition: HIV Infections
Intervention: Procedure: echocardiography and blood test
4 Completed Male Circumcision for HIV Prevention in Rakai, Uganda
Conditions: HIV Infections;   Herpesvirus 2, Human;   Syphilis;   Genital Diseases, Male
Intervention: Procedure: Adult male circumcision
5 Completed Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: ritonavir
6 Completed Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults
Condition: HIV Infections
Interventions: Biological: EP-1233;   Biological: MVA-mBN32
7 Recruiting Oral Human Papillomavirus Infection in HIV-infected Men
Conditions: Papillomavirus Infections;   HIV Infections
Intervention: Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
8 Completed Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial
Condition: HIV Infections
Intervention: Behavioral: Nutritional
9 Active, not recruiting Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men
Conditions: Anus Neoplasms;   HIV Infections
Intervention: Procedure: Argon Plasma Coagulation
10 Unknown  Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
Conditions: HIV Infections;   Tuberculous Meningitis
Intervention: Drug: Combivir and efavirenz
11 Active, not recruiting
Has Results
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
Condition: HIV Infections
Interventions: Drug: Tenofovir DF;   Drug: Zidovudine;   Drug: Stavudine
12 Completed Pain and Sensory Changes Assessment in HIV+ Patients
Condition: HIV Infections
Intervention:
13 Unknown  SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
Conditions: HIV Infections;   Lipodystrophy
Interventions: Drug: atazanavir (Reyataz);   Drug: ritonavir (Norvir)
14 Completed Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients
Conditions: HIV Infections;   Malaria
Intervention: Drug: Atovaquone / Proguanil
15 Terminated Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
Condition: HIV Infections
Interventions: Drug: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine);   Drug: d4T/3TC/NVP (stavudine/lamivudine/nevirapine);   Drug: AZT/3TC/ABC (zidovudine/lamivudine/abacavir);   Drug: d4T/3TC/ABC (stavudine/lamivudine/abacavir);   Drug: ddI/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir);   Drug: ABC/ ddI or TDF / NVP or EFV (abacavir / didanosine or tenofovir / nevirapine or efavirenz);   Drug: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)
16 Terminated Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya
Condition: HIV Infections
Interventions: Drug: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine);   Drug: d4T/3TC/NVP (stavudine/lamivudine/nevirapine);   Drug: AZT/3TC/ABC (zidovudine/lamivudine/abacavir);   Drug: d4T/3TC/ABC (stavudine/lamivudine/abacavir);   Drug: ddl/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir);   Drug: AZT/3TC/ LPV/r (zidovudine/lamivudine/ lopinavir-ritonavir);   Drug: - ABC/ddI or TDF/NVP or EFV (abacavir/didanosine or tenofovir/nevirapine or efavirenz);   Drug: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)
17 Completed Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals
Condition: HIV Infections
Interventions: Drug: Placebo;   Drug: Aprepitant
18 Completed
Has Results
Expanded Access Program for Maraviroc At Multiple Centers
Condition: Advanced HIV Infection
Intervention: Drug: maraviroc
19 Completed Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children
Condition: HIV
Interventions: Behavioral: Teaching, Raising, and Communicating with Kids (TRACK);   Other: Treatment as usual
20 Completed A Trial of Zinc and Micronutrients in Tanzanian Children
Conditions: Diarrheal Illnesses;   Respiratory Illness;   Growth Faltering
Interventions: Drug: Zinc;   Drug: Multivitamins;   Drug: Placebo

Indicates status has not been verified in more than two years